ARTICLE
Specificity of attention and cognitive inhibition processes in relapsing-remitting multiple sclerosis patients with consideration of their mood level.
1
Zakład Psychologii Klinicznej i Psychoprofilaktyki, Instytut Psychologii, Uniwersytet Szczeciński
2
Katedra i Klinika Psychiatrii, Pomorski Uniwersytet Medyczny
3
1. Zakład Psychologii Klinicznej i Psychoprofilaktyki, Instytut Psychologii, Uniwersytet Szczeciński
2. Katedra i Klinika Psychiatrii, Pomorski Uniwersytet Medyczny
Submission date: 2013-09-27
Final revision date: 2013-12-11
Acceptance date: 2013-12-12
Publication date: 2014-04-20
Corresponding author
Agnieszka Samochowiec
1. Zakład Psychologii Klinicznej i Psychoprofilaktyki, Instytut Psychologii, Uniwersytet Szczeciński 2. Katedra i Klinika Psychiatrii, Pomorski Uniwersytet Medyczny, Krakowska 69, 71-017 Szczecin, Polska
1. Zakład Psychologii Klinicznej i Psychoprofilaktyki, Instytut Psychologii, Uniwersytet Szczeciński 2. Katedra i Klinika Psychiatrii, Pomorski Uniwersytet Medyczny, Krakowska 69, 71-017 Szczecin, Polska
Psychiatr Pol 2014;48(2):307–318
KEYWORDS
TOPICS
ABSTRACT
Objectives:
The results of contemporary neuropsychological analyses lay foundation for a broad discussion of the nature and causes of cognitive deficits in MS patients. The aim of this study was to determine the level of alternating attention and dominant reaction inhibition in relapsing-remitting multiple sclerosis patients, with consideration of their mood level, age and disease duration.
Methods:
Experimental group consisted of 43 adults (30 women and 13 men) diagnosed with relapsing-remitting multiple sclerosis, with Extended Disability Status Scale (EDSS) results ranging between 2.5-6.5. Control group comprised 38 healthy adults (26 women and 12 men) selected according to sex, age and education. The following tasks were used in the study: the Trail Making Test A and B (TMT), Stroop Colour-Word Test (SCWT), and Beck Depression Inventory (BDI).
Results:
Experimental group was characterised by significantly worse performance in TMT (p<0.001) and SCWT (p<0.001) than the control group. No differences were observed in performance of TMT (p>0.05) and SCWT (p>0.05) in the experimental group between subjects with depressed and neutral mood. Disease duration proved significantly related to the level of dominant reaction inhibition (p<0.001).
Conclusions:
Cognitive impairments within areas of concentration, attention shifting and dominant reaction inhibition were all revealed in the experimental group.
The results of contemporary neuropsychological analyses lay foundation for a broad discussion of the nature and causes of cognitive deficits in MS patients. The aim of this study was to determine the level of alternating attention and dominant reaction inhibition in relapsing-remitting multiple sclerosis patients, with consideration of their mood level, age and disease duration.
Methods:
Experimental group consisted of 43 adults (30 women and 13 men) diagnosed with relapsing-remitting multiple sclerosis, with Extended Disability Status Scale (EDSS) results ranging between 2.5-6.5. Control group comprised 38 healthy adults (26 women and 12 men) selected according to sex, age and education. The following tasks were used in the study: the Trail Making Test A and B (TMT), Stroop Colour-Word Test (SCWT), and Beck Depression Inventory (BDI).
Results:
Experimental group was characterised by significantly worse performance in TMT (p<0.001) and SCWT (p<0.001) than the control group. No differences were observed in performance of TMT (p>0.05) and SCWT (p>0.05) in the experimental group between subjects with depressed and neutral mood. Disease duration proved significantly related to the level of dominant reaction inhibition (p<0.001).
Conclusions:
Cognitive impairments within areas of concentration, attention shifting and dominant reaction inhibition were all revealed in the experimental group.
Project no. RCN/SN/0610/2021/1 implemented from 2022 to 2024
Total value of the project: PLN 490 000
Amount funded by the MEiN: PLN 100 000
Aims of the project: Publication in Open Access mode on the Internet of English and Polish language versions of 12 consecutive issues of the journal Psychiatria Polska (years 2022-2024). Modernization and redesign of the journal’s website. Financing of the Editorial System. Copy editing and proofreading of journal issues. Counteracting scientific misinformation. Submission of electronic versions of the journal to the National Digital Library Polona and the Digital Library of Scientific Publications Academica.
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.